(Q43614773)

25 November 2017

title

Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial (English)

1 reference

25 November 2017

author

Isabelle Poizot-Martin

5

object named as

I Poizot-Martin

1 reference

25 November 2017

L Bentz

1

1 reference

25 November 2017

P Enel

2

1 reference

25 November 2017

B Dunais

3

1 reference

25 November 2017

J Durant

4

1 reference

25 November 2017

C Tourette-Turgis

6

1 reference

25 November 2017

M Rebillon

7

1 reference

25 November 2017

F Le Duff

8

1 reference

25 November 2017

P Dellamonica

9

1 reference

25 November 2017

C Pradier

10

1 reference

25 November 2017

publication date

1 December 2010

1 reference

25 November 2017

1 reference

25 November 2017

volume

22

1 reference

25 November 2017

issue

12

1 reference

25 November 2017

page(s)

1509-1516

1 reference

A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Factors affecting adherence to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Post-exposure HIV prophylaxis following sexual exposure: a retrospective audit against recent draft BASHH guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Diagnostic Value of Different Adherence Measures Using Electronic Monitoring and Virologic Failure as Reference Standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

UK Guideline for the use of post-exposure prophylaxis for HIV following sexual exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Postexposure prophylaxis after sexual exposure to HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Why do we need randomised controlled trials to assess behavioural interventions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

Physicians’ and patients’ adherence to antiretroviral prophylaxis after sexual exposure to HIV: results from South-Eastern France

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540121.2010.484457

10.1080/09540121.2010.484457

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference